Hierkunt u lezen, wie ik ben, wat ik heb meegemaakt en wat mijn professionele passies zijn.
Dr. Barentsz is MD since 1980 and received his research PhD in 1990. He is a Professor of Radiology since 1998 and currently the Chair of the Radboudumc Prostate MR-Reference Center.
His research led to the implementation of PI-RADS in 2012, which became the world-standard for prostate MRI. The '4M' paper from his group and other articles were the basis for the change of the European and Dutch prostate cancer guidelines. Now, it is recommended to use prostate-MRI before a biopsy.
His work also led to the "rebirth" of ferumoxtran-10 MRI, using dextran-coated iron nanoparticles as an MRI contrast agent to detect 2 mm lymph node micro-metastases. A marketing-approval trial in Germany, Switzerland and The Netherlands started in early 2020.
Dr. Barentsz' research focuses on the following aims:
1. Implementation of PSA + prostate-MRI for early detection of prostate cancer. Use of artificial intelligence for quality control of prostate MR-image-acquisition and -interpretation.
2. Providing international virtual interactive, hands-on education to help radiologists become prostate-MRI experts. To achieve this, he is also working to implement quality control through accreditation and certification, and he is establishing an (inter)national prostate-MRI excellence network.
3. Enable global marketing-approval of ferumoxtran-10 as MR-contrast agent, and implement nano-MRI as guidance for focal radiotherapy to treat nodal micro-metastases.
He can be stubborn, choosing to go left when everyone else goes right, if he believes it is the best path. He is determined in his decisions, but remains open to good ideas. For instance, when he proposed using MRI to detect clinically significant prostate cancer, urologists initially opposed the idea. However, he never gave up and has now been recognized with the EAU Innovators in Urology Award 2020 by European urologists. He also holds the position of Imaging Editor on the Executive Editorial Board of European Urology, where he strives to promote imaging tools that benefit patients. In his pursuit of these goals, he can sometimes become impatient, driven by his strong commitment and passion. However, he occasionally forgets that changes in medical care may take time. He is frequently sought after as a member of the Prostate Cancer Patient Society's Advisory Board, and willingly assists many patients, even outside normal working hours, providing them with (imaging) support.
In addition, he actively contributes to research in the field of prostate cancer imaging and therapy. His expertise and dedication have made him a respected figure in the medical community. He is known for his willingness to go above and beyond helping patients, even providing support outside of regular working hours.
He has authored over 350 papers, with seven published within the past two years and having a high-impact factor (> 20). His h-factor is 101, with more than 40,000 citations. Consequently, he has inspired numerous young researchers to produce exceptional articles.
Furthermore, he frequently presents his work at national and international conferences, contributing to the dissemination of knowledge in the field. He actively participates in collaborations with other institutions and clinicians, aiming to advance the effectiveness and accessibility of prostate cancer diagnosis and treatment.
Moreover, his dedication to education is evident in his role as a mentor and supervisor for medical students, residents, and fellows interested in prostate cancer imaging and therapy.
Patients and colleagues alike appreciate his approachable and compassionate nature, as he takes the time to listen attentively to their concerns, and ensure that they are well-informed and comfortable with their treatment plans. He consistently demonstrates a commitment to individualized care, tailoring approaches to the unique needs of each patient.
Overall, his expertise, passion for research, and patient-centred approach have made him a highly regarded specialist in prostate cancer imaging and therapy, shaping the standard of care in this important area of medicine.
He is very active on social media: he has more than 2000 expert-prostate followers on X and more than 1000 followers on LinkedIn.
- Royal Decoration: Knight in the Order of the Dutch Lion